Creo Medical Limited
CREO.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£27,800 | -£21,700 | -£26,936 | -£24,595 |
| Dep. & Amort. | £2,500 | £3,400 | £3,113 | £2,562 |
| Deferred Tax | £0 | £0 | £239 | -£1,926 |
| Stock-Based Comp. | £1,500 | £1,200 | £1,400 | £2,564 |
| Change in WC | -£100 | -£5,500 | -£2,820 | -£4,262 |
| Other Non-Cash | £1,700 | £1,000 | £16 | -£323 |
| Operating Cash Flow | -£22,200 | -£21,600 | -£24,988 | -£25,980 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£300 | -£1,200 | -£3,274 | -£6,122 |
| Net Acquisitions | £0 | -£2,400 | -£2,753 | -£1,752 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £15,600 | -£14,700 | £0 | £0 |
| Investing Cash Flow | £15,300 | -£18,300 | -£6,027 | -£7,874 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £5,800 | -£1,200 | £1,279 | -£1,700 |
| Stock Issued | £11,100 | £31,700 | £70 | £34,208 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£700 | -£700 | -£949 | -£515 |
| Financing Cash Flow | £16,200 | £29,800 | £400 | £31,993 |
| Forex Effect | £0 | £3 | £56 | £303 |
| Net Chg. in Cash | £9,300 | -£10,100 | -£30,437 | -£1,558 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £3,000 | £13,100 | £43,534 | £45,092 |
| End Cash | £12,300 | £3,000 | £13,097 | £43,534 |
| Free Cash Flow | -£22,600 | -£22,800 | -£28,262 | -£32,102 |